Company intelligence / Profile preview

THRUST Strategic Communications

Ownership: Private
Employees: ~5
Development stage: Other

Overview

THRUST Strategic Communications is an elite strategic advisory firm specializing in financing, investor relations, and corporate communications for life sciences companies. The team consists of senior-level experts with direct experience at public biopharma companies. They have supported over $10 billion in capital raises, executed more than 35 IPOs, and provided counsel through regulatory reviews and product launches for clients across the biotech/pharma sector.

Industry: Consulting

Partnerships

Autobahn TherapeuticsSepternaApogee Therapeutics

Beyond the preview

Go deeper on THRUST Strategic Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on THRUST Strategic Communications.

Explore the full profile